Product Information
CANDESARTAN CILEXETIL 16 MG TB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.4788 per EA under NDC 00378323193. Its NADAC has been published 337 times since Mar 11, 2020.
FDA first approved this application on May 3, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
16 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378323193
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CANDESARTAN CILEXETILApproval Type
Generic (ANDA)
FDA Application
ANDA078702FDA Approved
5/3/2013
TE Code
AB
On Market Since
1/6/2020
Pharmacological Classes
Price Statistics
The NADAC for CANDESARTAN CILEXETIL 16 MG TB has been published 337 times since Mar 11, 2020, and over the history we have for it it has declined 54.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4788 per EA |
|---|---|
| All-time high | $1.2630 (Apr 15, 2020) |
| All-time low | $0.4421 (May 22, 2024) |
| 52-week high | $0.6089 |
| 52-week low | $0.4745 |
| Median price | $0.7194 |
| Average price | $0.7178 |
| Largest weekly change | +37.7% (Nov 17, 2021) |
| Weeks tracked | 337 |
| Tracking since | Mar 11, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CANDESARTAN CILEXETIL 16 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for CANDESARTAN CILEXETIL 16 MG TB, manufactured by Mylan Pharmaceuticals Inc., is $0.4788 per EA (NDC 00378323193), effective Aug 19, 2026.
How has the price of CANDESARTAN CILEXETIL 16 MG TB changed over time?
Over the history we have for it, the NADAC for CANDESARTAN CILEXETIL 16 MG TB has declined 54.3%. It has been tracked across 337 weekly CMS publications since Mar 11, 2020.
What are the highest and lowest recorded NADAC prices for CANDESARTAN CILEXETIL 16 MG TB?
Since Mar 11, 2020, the NADAC for CANDESARTAN CILEXETIL 16 MG TB has ranged from a low of $0.4421 (May 22, 2024) to a high of $1.2630 (Apr 15, 2020), with a median of $0.7194 per EA.
Are there cheaper alternatives to CANDESARTAN CILEXETIL 16 MG TB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CANDESARTAN CILEXETIL 16 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures CANDESARTAN CILEXETIL 16 MG TB?
CANDESARTAN CILEXETIL 16 MG TB (NDC 00378323193) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.